SCHEMBL8106736

SCHEMBL8106736

CC1(C)CCC(C)(C)c2cc(NCC(=O)O)ccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 10/20 0.56
CYP26B1 Q9NR63 8/20 0.56
RARB P10826 7/20 0.56
RARG P13631 7/20 0.56
RARA P10276 6/20 0.56
CYP3A4 P08684 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
PGR P06401 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
TBXA2R P21731 1/20 0.56
BLVRB P30043 1/20 0.56
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C19 P33261 1/20 0.52
RXRA P19793 6/20 0.48
RXRB P28702 6/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8100688 0.85 CYP26A1 (0.50) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL32685293 0.79 RARB (0.68) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL3943886 0.78 CYP26A1 (0.48) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL5084737 0.77 RARB (0.66) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL29569037 0.77 RARB (0.66) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL5888067 0.77 RARB (0.66) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL1615912 0.76 RARB (0.65) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL3935697 0.76 RARB (0.64) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL8461595 0.76 RARB (0.63) CYP26A1CYP26B1RARBRARGRARA
SCHEMBL13027028 0.75 CYP26A1 (0.68) CYP26A1CYP26B1RARBRARGRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051243-A USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-04-18 US disclosed
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US disclosed
EP-0661260-B1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CIRD GALDERMA (FR) 1997-03-12 EP disclosed
EP-0661260-A1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-07-05 EP disclosed